NAVXCELL

Welcome to the Brand page for “NAVXCELL”, which is offered here for Biotechnological platform technology, cell lines for preparation of biological vectors, and recombinant viruses for gene delivery, that includes recombinant adeno-associated viral (raav) vectors to provide a platform for specific production of biologics with therapeutic effect in gene therapy, including gene therapy delivery of antibody biologics, enzymes and rna interference (rnai);.

Its status is currently believed to be active. Its class is unavailable. “NAVXCELL” is believed to be currently owned by “REGENXBIO INC.”